CORAL LABORATORIES
|
CORAL LABORATORIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 67.61 | 44.19 | 18.04 | 25.32 | 37.94 |
| CEPS(Rs) | 73.24 | 49.72 | 24.14 | 30.89 | 43.49 |
| DPS(Rs) | 1.50 | 2.00 | - | - | - |
| Book NAV/Share(Rs) | 563.19 | 496.83 | 433.29 | 436.81 | 382.48 |
| Tax Rate(%) | 25.61 | 23.84 | 21.65 | 23.70 | 23.04 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 22.82 | 19.41 | 4.88 | 10.86 | 16.41 |
| EBIT Margin(%) | 28.32 | 24.78 | 10.96 | 15.87 | 18.28 |
| Pre Tax Margin(%) | 28.23 | 24.78 | 10.53 | 15.68 | 18.24 |
| PAT Margin (%) | 21.00 | 18.87 | 8.25 | 11.96 | 14.04 |
| Cash Profit Margin (%) | 22.75 | 21.23 | 11.04 | 14.60 | 16.09 |
| Performance Ratios | |||||
| ROA(%) | 11.10 | 8.31 | 3.54 | 5.06 | 8.69 |
| ROE(%) | 12.76 | 9.50 | 4.15 | 6.18 | 10.74 |
| ROCE(%) | 17.04 | 12.48 | 5.41 | 7.87 | 13.35 |
| Asset Turnover(x) | 0.53 | 0.44 | 0.43 | 0.42 | 0.62 |
| Sales/Fixed Asset(x) | 2.29 | 1.68 | 1.64 | 1.74 | 2.36 |
| Working Capital/Sales(x) | 0.76 | 0.65 | 0.70 | 0.72 | 0.96 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.44 | 0.59 | 0.61 | 0.58 | 0.42 |
| Receivable days | 98.13 | 112.59 | 143.76 | 186.51 | 139.03 |
| Inventory Days | 39.72 | 60.34 | 72.11 | 96.64 | 77.43 |
| Payable days | 102.34 | 146.79 | 75.80 | 167.30 | 164.79 |
| Valuation Parameters | |||||
| PER(x) | 10.37 | 8.40 | 12.69 | 10.08 | 8.49 |
| PCE(x) | 9.58 | 7.47 | 9.48 | 8.26 | 7.41 |
| Price/Book(x) | 1.25 | 0.75 | 0.53 | 0.58 | 0.84 |
| Yield(%) | 0.21 | 0.54 | - | - | - |
| EV/Net Sales(x) | 1.52 | 0.85 | 0.53 | 0.79 | 0.90 |
| EV/Core EBITDA(x) | 4.93 | 3.12 | 3.86 | 4.59 | 4.41 |
| EV/EBIT(x) | 5.35 | 3.44 | 4.83 | 4.98 | 4.90 |
| EV/CE(x) | 0.85 | 0.40 | 0.27 | 0.31 | 0.52 |
| M Cap / Sales | 2.18 | 1.59 | 1.05 | 1.21 | 1.19 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 37.47 | 7.09 | 3.32 | -21.70 | 36.82 |
| Core EBITDA Growth(%) | 54.55 | 113.62 | -17.82 | -33.60 | 73.39 |
| EBIT Growth(%) | 57.09 | 142.07 | -28.61 | -32.05 | 89.67 |
| PAT Growth(%) | 52.99 | 144.97 | -28.75 | -33.26 | 90.10 |
| EPS Growth(%) | 52.99 | 144.97 | -28.75 | -33.26 | 90.10 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | - | - | 0.04 | 0.05 |
| Current Ratio(x) | 7.07 | 6.18 | 10.42 | 5.13 | 4.67 |
| Quick Ratio(x) | 6.68 | 5.57 | 9.36 | 4.41 | 3.88 |
| Interest Cover(x) | 333.69 | - | 25.30 | 85.02 | 415.41 |
| Total Debt/Mcap(x) | 0.01 | - | - | 0.07 | 0.05 |
Compare Financial Ratios of peers of CORAL LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORAL LABORATORIES | ₹179.8 Cr | 2.6% | -3.2% | -40.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,477.0 Cr | 2.5% | 4% | -3.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,934.0 Cr | -1% | 0.5% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,469.0 Cr | 6.9% | 8.7% | 21% | Stock Analytics | |
| CIPLA | ₹123,250.0 Cr | 1.4% | -2.4% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,038.0 Cr | 2.4% | -2.2% | -4.5% | Stock Analytics | |
CORAL LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORAL LABORATORIES | 2.6% |
-3.2% |
-40.9% |
| SENSEX | 1.4% |
2.4% |
5.1% |
You may also like the below Video Courses
